Dose escalation and associated costs in biologic treatment of psoriasis based on real-world data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose escalation and associated costs in biologic treatment of psoriasis based on real-world data

Published:2021-01-01 Issue:1 Volume:24 Page:782-791
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Bagel Jerry¹,Glick Brad²,Wu Jashin J.³,Chopra Ishveen⁴,Song Xue⁴,Brouillette Matthew⁴,Mendelsohn Alan⁵,Rozzo Stephen⁵,Han George⁶

Affiliation:

1. Psoriasis Treatment Center of Central New Jersey, East Windsor, NJ, USA

2. Glick Skin Institute, Margate, FL, USA

3. Dermatology Research and Education Foundation, Irvine, CA, USA

4. Outcomes Research, IBM Watson Health, Cambridge, MA, USA

5. Sun Pharmaceutical Industries, Inc, Princeton, NJ, USA

6. Icahn School of Medicine at Mount Sinai, New York, NY, USA

Funder

Sun Pharmaceutical Industries, Inc

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1937187

Reference8 articles.

1. Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment Dissatisfaction

2. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients

3. Managing the dose escalation of biologics in an era of cost containment: the need for a rational strategy

4. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis

5. Economic Burden of Psoriasis in the United States

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose escalation of biologic treatment in patients with moderate‐to‐severe psoriasis in Japan;Experimental Dermatology;2024-05

2. Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain;Actas Dermo-Sifiliográficas;2024-01

3. [Artículo traducido] Gravedad de la psoriasis, calidad de vida relacionada con la salud, productividad laboral y deterioro de la actividad en pacientes con psoriasis moderada a grave que reciben tratamiento sistémico: datos de la vida real de la práctica clínica en España;Actas Dermo-Sifiliográficas;2024-01

4. Reduced doses of biological therapies in psoriasis: a new potentially “sustainable” frontier of psoriasis treatment;Expert Opinion on Biological Therapy;2023-08-08

5. Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States;Journal of Dermatological Treatment;2023-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3